by Newcastle University Credit: Pixabay/CC0 Public DomainA pioneering drug for a rare kidney disease prevents organ failure and significantly improves the outcome for patients, new research has confirmed. Atypical hemolytic uraemic syndrome (aHUS) is a genetic life-threatening condition caused by a defect in the immune system which leads to kidney failure. Newcastle University, UK, carried...
